Clinical Trials
3 trialsNCT07241416 2026-05-11
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Recruiting
NCT06392841 2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2 Withdrawn
NCT07216248 2025-10-29
OPTIMAS
University of Utah
Phase 2 Recruiting